80 related articles for article (PubMed ID: 8100640)
21. Effect of the vascular endothelium on contractions induced by noradrenaline and phenylephrine in perforating branch of the human internal mammary artery.
Pesić S; Grbović L; Jovanović A; Radenković M; Stojić D
Pol J Pharmacol; 2003; 55(4):581-93. PubMed ID: 14581717
[TBL] [Abstract][Full Text] [Related]
22. Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature.
Owen MP
J Pharmacol Exp Ther; 1993 May; 265(2):887-95. PubMed ID: 8496832
[TBL] [Abstract][Full Text] [Related]
23. A new in vitro method of decongestant assay of nasal mucosa: a preliminary report.
Wang HW; Kao CH; Chu YH
Am J Rhinol; 2006; 20(1):43-7. PubMed ID: 16539294
[TBL] [Abstract][Full Text] [Related]
24. Vascular effects of neuropeptides on nasal mucosa.
Ichimura K; Mineda H; Seki A
Ann Otol Rhinol Laryngol; 1988; 97(3 Pt 1):289-93. PubMed ID: 2454064
[TBL] [Abstract][Full Text] [Related]
25. The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog.
Corder R; Lowry PJ; Withrington PG
Br J Pharmacol; 1987 Apr; 90(4):785-90. PubMed ID: 3580708
[TBL] [Abstract][Full Text] [Related]
26. [NPY in human nasal mucosa -- an immunocytochemical and immunoelectron microscopical study].
Knipping S; Holzhausen HJ; Riederer A; Berghaus A
Laryngorhinootologie; 2003 Feb; 82(2):109-13. PubMed ID: 12624839
[TBL] [Abstract][Full Text] [Related]
27. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
Hoyo Y; McGrath JC; Vila E
J Pharmacol Exp Ther; 2000 Jul; 294(1):38-44. PubMed ID: 10871293
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of alpha 2-adrenoceptor-mediated responses in pig nasal mucosa.
Corboz MR; Varty LM; Rizzo CA; Mutter JC; Rivelli MA; Wan Y; Umland S; Qiu H; Jakway J; McCormick KD; Berlin M; Hey JA
Auton Autacoid Pharmacol; 2003 Aug; 23(4):208-19. PubMed ID: 15084187
[TBL] [Abstract][Full Text] [Related]
29. Effects of neuropeptide Y on cochlear blood flow in guinea pigs.
Itou M; Ogawa K; Inoue Y; Sato M; Kanzaki J
Acta Otolaryngol; 2001 Jul; 121(5):573-8. PubMed ID: 11583388
[TBL] [Abstract][Full Text] [Related]
30. Functional effects of neuropeptide Y receptors on blood flow and nitric oxide levels in the human nose.
Cervin A; Onnerfält J; Edvinsson L; Grundemar L
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1724-8. PubMed ID: 10556147
[TBL] [Abstract][Full Text] [Related]
31. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
Modin A; Malmström RE; Meister B
Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
[TBL] [Abstract][Full Text] [Related]
32. Effect of cooling on electrical field stimulation and norepinephrine-induced contraction in isolated hypertrophic human nasal mucosa.
Chu YH; Wu CC; Wang HW
Am J Rhinol; 2006; 20(5):471-5. PubMed ID: 17063740
[TBL] [Abstract][Full Text] [Related]
33. Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.
Nilsson T; Lind H; Brunkvall J; Edvinsson L
Can J Physiol Pharmacol; 2000 Mar; 78(3):251-5. PubMed ID: 10721817
[TBL] [Abstract][Full Text] [Related]
34. [The effect of endothelin on neurotransmitter regulation of vascular tension in the nasal mucosa].
Okita W; Ichimura K; Tanaka T; Iinuma T
Nihon Jibiinkoka Gakkai Kaiho; 1992 Feb; 95(2):187-94. PubMed ID: 1560304
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism.
Fallgren B; Arlock P; Edvinsson L
J Auton Nerv Syst; 1993; 44(2-3):151-9. PubMed ID: 8227954
[TBL] [Abstract][Full Text] [Related]
36. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide Y is a vasoconstrictor in human nasal mucosa.
Baraniuk JN; Silver PB; Kaliner MA; Barnes PJ
J Appl Physiol (1985); 1992 Nov; 73(5):1867-72. PubMed ID: 1282125
[TBL] [Abstract][Full Text] [Related]
38. Beta-adrenergic mechanisms in the nasal mucosa vascular bed.
Lacroix JS; Kurt AM; Auberson S; Bretton C
Eur Arch Otorhinolaryngol; 1995; 252(5):298-303. PubMed ID: 7576588
[TBL] [Abstract][Full Text] [Related]
39. Inotropic effects of calcitonin gene-related peptide, vasoactive intestinal polypeptide and somatostatin on the human right atrium in vitro.
Franco-Cereceda A; Bengtsson L; Lundberg JM
Eur J Pharmacol; 1987 Jan; 134(1):69-76. PubMed ID: 2881795
[TBL] [Abstract][Full Text] [Related]
40. Eicosapentaenoic acid inhibits vasoconstrictor- and noradrenaline-potentiating effects of neuropeptide Y in the isolated rabbit ear.
Juan H; Sametz W; Saria A; Pöch G
J Auton Nerv Syst; 1988 Apr; 22(3):237-42. PubMed ID: 2843588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
